US Justice Department intervenes in Rapamune whistleblower suit against Pfizer
This article was originally published in Scrip
Executive Summary
The US Justice Department has decided to join a whistleblower lawsuit accusing Pfizer's Wyeth unit of promoting the kidney-transplant drug Rapamune (sirolimus) for off-label uses and offering kickbacks to providers.